A new treatment for prostate cancer developed and trialled in London has been licensed for use.
Enzalutamide was developed by researchers at the Royal Marsden and University College London hospitals.
The one a day pill checks the spread of the cancer.
Reseachers say the most exciting aspect of this new drug is that is has very few side effects- unlike many cancer treatements.
More top news
High level of cloud will turn this morning's sunshine increasingly hazy. Tonight will stay dry with clear spells.
The eight-week old British Bulldog puppy is so valuable because of its rare colouring.
E-cigarettes have been banned on London buses. Smokers who switch to electronic devices are already prevented from using them on the tube.